Volume 89, Issue 3
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



French Guiana, the French territory most affected by human immunodeficiency virus (HIV) (1.3% of pregnant women), is also endemic for human T lymphotropic virus 1 (HTLV1). The objective of this study was to determine if the HTLV1/HIV coinfected patients had particular characteristics. All HIV-infected patients having a computerized medical file containing an HTLV1 serology were included: there were 1,333 HIV monoinfections and 76 HTLV1/VIH coinfections. The prevalence of HTLV1/HIV coinfections was 5.39%. Women (odds ratio [OR] = 1.91[1.13–3.24]), subjects > 40 years of age, and patients of Surinamese origin (OR = 2.65 [1.25–5.61]) were overrepresented among the coinfected. CD4 count at the time of diagnosis and viral loads were higher among coinfected patients. The clinical stage was not significantly different between the two groups. The number of CD4 cells was not higher among the coinfected, unlike most reports from the literature. Prevalence of HTLV1 among HIV-infected patients is high in French Guiana, and physicians seem to omit the prescription of serology for this potentially serious coinfection.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Nacher M, Huber F, El Guedj M, Vaz T, Magnien C, Djossou F, Randrianjohany A, Alvarez F, Couppié P, , 2007. Risk factors for death among patients in French Guiana: 1996–2005. HIV Med 8: 472474.[Crossref] [Google Scholar]
  2. Nacher M, Vantilcke V, Parriault MC, Van Melle A, Hanf M, Labadie G, Romeo M, Adriouch L, Carles G, Couppié P, , 2010. What is driving the HIV epidemic in French Guiana? Int J STD AIDS 21: 359361.[Crossref] [Google Scholar]
  3. Nacher M, , 2007. Activity Report of HIV Patient Care in French Guiana in 2007. Available at: www.corevih.org. Accessed June 27, 2013. [Google Scholar]
  4. Kazanji M, Gessain A, , 2003. Human T-cell lymphotropic virus types I and II (HTLV-I/II) in French Guiana: clinical and molecular epidemiology. Cad Saude Publica 19: 12271240.[Crossref] [Google Scholar]
  5. Verdonck K, Gonzalez E, Van Dooren S, Vandamme AM, Vanham G, Gotuzzo E, , 2007. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis 7: 266281.[Crossref] [Google Scholar]
  6. Plancoulaine S, Gessain A, Joubert M, Tortevoye P, Jeanne I, Talarmin A, de Thé G, Abel L, , 2000. Detection of a major gene predisposing to human T lymphotropic virus type I infection in children among an endemic population of African origin. J Infect Dis 182: 405412.[Crossref] [Google Scholar]
  7. Casoli C, Pilotti E, Bertazzoni U, , 2007. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression. AIDS Rev 9: 140149. [Google Scholar]
  8. Beilke MA, Traina-Dorge VL, Sirois M, Bhuiyan A, Murphy EL, Walls JM, Fagan R, Winsor EL, Kissinger PJ, , 2007. Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection. Clin Infect Dis 44: 12291234.[Crossref] [Google Scholar]
  9. Brites C, Sampalo J, Oliveira A, , 2009. HIV/human T-cell lymphotropic virus coinfection revisited: impact on AIDS progression. AIDS Rev 11: 816. [Google Scholar]
  10. Sobesky M, Couppie P, Pradinaud R, Godard MC, Alvarez F, Benoit B, Carme B, Lebeux P, , 2000. Coinfection with HIV and HTLV-I infection and survival in AIDS stage. French Guiana Study. GECVIG (Clinical HIV Study Group in Guiana). Presse Med 29: 413416. [Google Scholar]
  11. Cabié A, , 2012. Activity Report of the COREVIH Martinique. Available at: http://www.sfls.aei.fr/ckfinder/userfiles/files/BAO-CoreVIH/bao8/RA_2011_COREVIH_Martinique.pdf. Accessed June 27, 2013. [Google Scholar]
  12. Césaire R, Lagathu G, Lézin A, . 2005. HTLV1 and associated diseases in the French Antilles and French Guiana. Revue Francophone des Laboratoires 2005: 3544.[Crossref] [Google Scholar]
  13. Plancoulaine S, Buigues RP, Murphy EL, van Beveren M, Pouliquen JF, Joubert M, Rémy F, Tuppin P, Tortevoye P, de Thé G, Moreau JP, Gessain A, , 1998. Demographic and familial characteristics of HTLV-1 infection among an isolated, highly endemic population of African origin in French Guiana. Int J Cancer 76: 331336.[Crossref] [Google Scholar]
  14. Beilke MA, Theall KP, Megan O, Clayton JL, Benjamin SM, Winsor EL, Kissinger PJ, , 2004. Clinical outcomes and disease progression among patients coinfected with HIV and human T lymphotropic virus types 1 and 2. Clin Infect Dis 39: 256263.[Crossref] [Google Scholar]
  15. Schechter M, Harrison LH, Halsey NA, Trade G, Santino M, Moulton LH, Quinn TC, , 1994. Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression. JAMA 271: 353357.[Crossref] [Google Scholar]
  16. Oni T, Djossou F, Joubert M, Heraud JM, , 2006. Awareness of mother-to-child transmission of human T-cell lymphotropic virus (HTLV) type I through breastfeeding in a small group of HTLV-positive women in Maripasoula and Papaichton, French Guiana. Trans R Soc Trop Med Hyg 100: 715718.[Crossref] [Google Scholar]
  17. Schechter M, Moulton LH, Harrison LH, , 1997. HIV viral load and CD4+ lymphocyte counts in subjects coinfected with HTLV-I and HIV-1. J Acquir Immune Defic Syndr Hum Retrovirol 15: 308311.[Crossref] [Google Scholar]
  18. Brites C, Alencar R, Gusmao R, Pedroso C, Netto EM, Pedral-Sampaio D, Badaró R, , 2001. Co-infection with HTLV-1 is associated with a shorter survival time for HIV-1-infected patients in Bahia, Brazil. AIDS 15: 20532055.[Crossref] [Google Scholar]
  19. Gudo ES, Bhatt NB, Bila DR, Abreu CM, Tanuri A, Savino W, Silva-Barbosa SD, Jani IV, , 2009. Co-infection by human immunodeficiency virus type 1 (HIV-1) and human T cell leukemia virus type 1 (HTLV-1): does immune activation lead to a faster progression to AIDS? BMC Infect Dis 9: 211.[Crossref] [Google Scholar]
  20. Scapellato PG, Bottaro E, Brieschke MT, Scapellato JL, Dato A, Intile AD, Davaro R, Vidal GI, , 2003. CD4 cell count among HIV-infected patients with an AIDS-defining disease: higher count in patients coinfected than in those not coinfected with human T-cell lymphotropic virus type I. J Acquir Immune Defic Syndr 33: 279280.[Crossref] [Google Scholar]
  21. Bessinger R, Beilke M, Kissinger P, Jarrott C, Tabak OF, , 1997. Retroviral coinfections at a New Orleans HIV outpatient clinic. J Acquir Immune Defic Syndr Hum Retrovirol 14: 6771.[Crossref] [Google Scholar]
  22. Harrison LH, Quinn TC, Schechter M, , 1997. Human T cell lymphotropic virus type I does not increase human immunodeficiency virus viral load in vivo . J Infect Dis 175: 438440.[Crossref] [Google Scholar]
  23. Cardoso DF, Souza FV, Fonseca LA, Duarte AJ, Casseb J, , 2009. Influence of human T-cell lymphotropic virus type 1 (HTLV-1) infection on laboratory parameters of patients with chronic hepatitis C virus. Rev Inst Med Trop Sao Paulo 51: 325329.[Crossref] [Google Scholar]

Data & Media loading...

  • Received : 20 Dec 2012
  • Accepted : 24 Feb 2013
  • Published online : 04 Sep 2013

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error